2.4% placebo (N=1,961) Oral semaglutide 50 mg / phase 3 OASIS-1 showed 15.1% weight loss at 68 weeks CagriSema / semaglutide + cagrilintide
Even with insurance, co-pays can be brutal, and many plans dont cover obesity medications at all
Kyruus Health partners with Abundant Health to integrate Kyruus Healths care access platform with ahas low-code/no-code platform directly within a health systems digital experience platform. VoiceCare AI pilots with Mayo Clinic for automated documentation
Clients choose us for provider-guided weight loss consultations, personalized metabolic wellness planning, education around GLP-1 and next-generation weight loss research, premium in-lounge and virtual care options, local access across NY, including NYC, Newburgh, Westchester, and the Hudson Valley, and integrated support with IV therapy, peptides, hormone wellness, recovery, and longevity optimization